home / stock / lgvn / lgvn news

LGVN News and Press, Longeveron Inc. From 10/05/22

Stock Information
Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com
Menu
LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...
LGVN - Longeveron to Present at the Annual Dawson James Small Cap Growth Conference

MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, announced today that Chris Min, M.D., Ph.D., Interim Chief Executive Officer, and Chief Medi...
LGVN - Longeveron Names Jerome Bailey Vice President of Business Operations

MIAMI, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced it has named Jerome Bailey as the company’s new vice president of business operations. He j...

LGVN - Longeveron (LGVN) Investor Presentation - Slideshow

The following slide deck was published by Longeveron Inc. in conjunction with this event. For further details see: Longeveron (LGVN) Investor Presentation - Slideshow

LGVN - Longeveron to Present at H.C. Wainwright 24th Annual Global Investment Conference

MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that Chris Min, M.D., Ph.D., Interim Chief Ex...
LGVN - PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/PhotobyTawat Pfizer (NYSE: PFE ) and Moderna (NASDAQ: MRNA ) stocks are in the news Wednesday as the FDA approves new booster shots for Covid-19. The new booster shots approved b...

LGVN - Why Is Longeveron (LGVN) Stock on the Move Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko Longeveron (NASDAQ: LGVN ) stock is on the move Wednesday after the FDA granted its fast-track designation for Lomecel-B . Lomecel-B is a allogeneic, bone marrow-d...

LGVN - Longeveron spikes after FDA's Fast Track Designation for lead candidate

The shares of clinical-stage biotech Longeveron Inc. ( NASDAQ: LGVN ) jumped in the pre-market trading Wednesday after the company announced that the FDA issued Fast Track Designation for its lead asset Lomecel-B as a treatment for Hypoplastic Left Heart Syndrome (HLHS). A...
LGVN - U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron's Lomecel-B(TM) Product for Treatment of Hypoplastic Left Heart Syndrome (HLHS) in Infants

MIAMI, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the U.S. Food and Drug Administration (FDA) ha...

LGVN - Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B(TM) Cell Therapy Through Levels of Vascular Biomarker

MIAMI, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, today announced that the European Patent Office (EPO) has issued a notice of its int...

LGVN - Longeveron Inc. (LGVN) CEO Chris Min on Q2 2022 Results - Earnings Call Transcript

Longeveron Inc. (LGVN) Q2 2022 Earnings Conference Call August 12, 2022 08:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief Executive Officer & Chief Medical Officer James Clavijo - Chief Financial Officer Joshu...
Previous 10 Next 10